NCT06271746View on ClinicalTrials.gov

Treatment of Fibromyalgia With the FibroNova Neuromodulation Device

NARecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

March 4, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

June 1, 2025

Conditions
Fibromyalgia
Interventions
DEVICE

FibroNova (Active mode)

FibroNova neurostimulator of conditional pain modulation (CPM)

DEVICE

FibroNova (Sham mode)

FibroNova neurostimulator with an electrical output not intended for neurostimulation

Trial Locations (4)

23454

RECRUITING

Gershon Pain Specialists, Virginia Beach

63005

RECRUITING

Clinical Research Professionals, Chesterfield

65807

RECRUITING

ClinVest Headlands Research, Springfield

6423906

NOT_YET_RECRUITING

Tel Aviv Sourasky Medical Center, Tel Aviv

Sponsors

Lead Sponsor

Theranica
All Listed Sponsors
lead

Theranica

INDUSTRY